Company intelligence / Profile preview

Adeptrix

Beverly, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

Adeptrix has commercialized several BAMS-based products and offers assay development services for pharma and clinical customers. Collaborations have included development and launch of SARS-CoV-2 BAMS research kits and significant partnerships.

Therapeutic areas: Other
Modalities: ProteinBiologic
Industry: Protein Biomarker Diagnostics

Partnerships

Bruker (collaboration on SARS-CoV-2 assay)Avacta Group (collaboration, primarily on Affimer-based BAMS COVID-19 assays)

Beyond the preview

Go deeper on Adeptrix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adeptrix.

Explore the full profile